Form D · Pharmaceuticals
Revalesio Corp
Tacoma, WA · CIK 0001552377
Offering snapshot reported Dec 16, 2025 · SEC filing
- Reported sold
- $38.9M Offering amount: $40.3M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 25, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$25,510,205 → $38,877,508
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 16, 2025 | Amendment | $38,877,508 | $13,367,303vs Apr 12, 2024 | 31 | SEC filing |
| Apr 12, 2024 | Amendment | $25,510,205 | $13,507,805vs Jun 9, 2022 | 31 | SEC filing |
| Jun 9, 2022 | Initial | $12,002,400 | No comparison | 20 | SEC filing |
| Jul 22, 2020 | Initial | $20,371,187 | No comparison | 22 | SEC filing |
| Jun 27, 2018 | Initial | $6,000,000 | No comparison | 6 | SEC filing |
| Jul 5, 2016 | Initial | $13,999,912 | No comparison | 11 | SEC filing |
| May 5, 2014 | Initial | $13,500,000 | No comparison | 3 | SEC filing |
| Jun 19, 2012 | Initial | $10,650,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-448647
Source: Form D, filed Dec 16, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Troy Alstead | Director |
| Greg Archambeau | Executive |
| Karl Bandlien | Director |
| Tom Bumol | Director |
| Bruce Buskirk | Executive |
| Patrick Caruana | Director |
| Chris Fibiger | Director |
| William Gallacher | Director |
| Liam Gallacher | Director |
| Lee Huntsman | Director |
| Matt Ireland | Director |
| James Nordstrom | Director |
| Jim Nordstrom | Director |
| Marsha Russell | Director |
| Eric Russell | Director |
| Jeffrey Smith | Director |
| Jane Taylor | Director |
| Bert Van Den Bergh | Director |
| Scott Walcheck | Director |
| Scott Walchek | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1202 E. D St
Tacoma, WA, 98421
Tacoma, WA, 98421